Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy.

ABSTRACT:

SUBMITTER: Atanasio A 

PROVIDER: S-EPMC10226289 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature